Clinical Trial Update: DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating a dendritic cell vaccine in combination with cytokine-induced killer cells for renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Cytokine-induced killer cells
• Dendritic cell vaccine therapy (dendritic cell vaccine)

Snippet

Sponsor: Fuzhou General Hospital | Conditions: Renal Cell Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN